{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:26:22Z","timestamp":1791901582636,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T00:00:00Z","timestamp":1421280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s40478-014-0179-6","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T11:00:36Z","timestamp":1421233236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis"],"prefix":"10.1186","volume":"3","author":[{"given":"Marie","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Bougoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Feferman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lin\u00e9e","family":"Frenkian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Clairac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C","family":"Souroujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,15]]},"reference":[{"key":"179_CR1","first-page":"96","volume":"102","author":"DB Drachman","year":"1977","unstructured":"Drachman DB, Kao L, Angus CW, Murphy A. Effect of myasthenic immunoglobulin on ACh receptors of cultured muscle. Trans Am Neurol Assoc. 1977;102:96\u2013100.","journal-title":"Trans Am Neurol Assoc"},{"key":"179_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","volume":"505","author":"FM Howard Jr","year":"1987","unstructured":"Howard Jr FM, Lennon VA, Finley J, Matsumoto J, Elveback LR. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci. 1987;505:526\u201338.","journal-title":"Ann N Y Acad Sci"},{"key":"179_CR3","first-page":"279","volume":"3","author":"S Fuchs","year":"1979","unstructured":"Fuchs S. Immunochemical analysis of acetylcholine receptor and its relevance to specific treatment of experimental autoimmune myasthenia gravis. Adv Cytopharmacol. 1979;3:279\u201385.","journal-title":"Adv Cytopharmacol"},{"key":"179_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1749-6632.1996.tb21134.x","volume":"778","author":"DB Drachman","year":"1996","unstructured":"Drachman DB, Okumura S, Adams RN, McIntosh KR. Oral tolerance in myasthenia gravis. Ann N Y Acad Sci. 1996;778:258\u201372.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"179_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1517\/14712598.5.7.983","volume":"5","author":"S Berrih-Aknin","year":"2005","unstructured":"Berrih-Aknin S, Fuchs S, Souroujon MC. Vaccines against myasthenia gravis. Expert Opin Biol Ther. 2005;5(7):983\u201395. doi:10.1517\/14712598.5.7.983.","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"179_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0014-5793(88)80442-3","volume":"233","author":"O Asher","year":"1988","unstructured":"Asher O, Neumann D, Fuchs S. Increased levels of acetylcholine receptor alpha-subunit mRNA in experimental autoimmune myasthenia gravis. FEBS Lett. 1988;233(2):277\u201381.","journal-title":"FEBS Lett"},{"issue":"1","key":"179_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1172\/JCI117302","volume":"94","author":"T Guyon","year":"1994","unstructured":"Guyon T, Levasseur P, Truffault F, Cottin C, Gaud C, Berrih-Aknin S. Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J Clin Invest. 1994;94(1):16\u201324. doi:10.1172\/JCI117302.","journal-title":"J Clin Invest"},{"issue":"1","key":"179_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1172\/JCI1248","volume":"102","author":"T Guyon","year":"1998","unstructured":"Guyon T, Wakkach A, Poea S, Mouly V, Klingel-Schmitt I, Levasseur P, et al. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. J Clin Invest. 1998;102(1):249\u201363. doi:10.1172\/JCI1248.","journal-title":"J Clin Invest"},{"issue":"11","key":"179_CR9","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.4049\/jimmunol.151.11.6442","volume":"151","author":"O Asher","year":"1993","unstructured":"Asher O, Kues WA, Witzemann V, Tzartos SJ, Fuchs S, Souroujon MC. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis. J Immunol. 1993;151(11):6442\u201350.","journal-title":"J Immunol"},{"issue":"2","key":"179_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2010.08.001","volume":"133","author":"R Planas","year":"2010","unstructured":"Planas R, Pujol-Borrell R, Vives-Pi M. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery. Immunol Lett. 2010;133(2):55\u201361.","journal-title":"Immunol Lett"},{"key":"179_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-immunol-030409-101221","volume":"28","author":"V Pascual","year":"2010","unstructured":"Pascual V, Chaussabel D, Banchereau J. A genomic approach to human autoimmune diseases. Annu Rev Immunol. 2010;28:535\u201371. doi:10.1146\/annurev-immunol-030409-101221.","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"179_CR12","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","volume":"174","author":"S Poea-Guyon","year":"2005","unstructured":"Poea-Guyon S, Christadoss P, Le Panse R, Guyon T, De Baets M, Wakkach A, et al. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. J Immunol. 2005;174(10):5941\u20139.","journal-title":"J Immunol"},{"issue":"11","key":"179_CR13","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","volume":"177","author":"R Le Panse","year":"2006","unstructured":"Le Panse R, Cizeron-Clairac G, Bismuth J, Berrih-Aknin S. Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia. J Immunol. 2006;177(11):7868\u201379.","journal-title":"J Immunol"},{"issue":"4","key":"179_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/ana.21628","volume":"66","author":"S Berrih-Aknin","year":"2009","unstructured":"Berrih-Aknin S, Ruhlmann N, Bismuth J, Cizeron-Clairac G, Zelman E, Shachar I, et al. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. Ann Neurol. 2009;66(4):521\u201331. doi:10.1002\/ana.21628.","journal-title":"Ann Neurol"},{"issue":"9","key":"179_CR15","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","volume":"174","author":"T Feferman","year":"2005","unstructured":"Feferman T, Maiti PK, Berrih-Aknin S, Bismuth J, Bidault J, Fuchs S, et al. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. J Immunol. 2005;174(9):5324\u201331.","journal-title":"J Immunol"},{"issue":"1\u20132","key":"179_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.01.021","volume":"209","author":"T Feferman","year":"2009","unstructured":"Feferman T, Aricha R, Mizrachi K, Geron E, Alon R, Souroujon MC, et al. Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3. J Neuroimmunol. 2009;209(1\u20132):87\u201395.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"179_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0019-2791(77)90291-9","volume":"14","author":"A Aharonov","year":"1977","unstructured":"Aharonov A, Tarrab-Hazdai R, Silman I, Fuchs S. Immunochemical studies on acetylcholine receptor from Torpedo californica. Immunochemistry. 1977;14(2):129\u201337.","journal-title":"Immunochemistry"},{"key":"179_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jneuroim.2008.06.028","volume":"201\u2013202","author":"G Cizeron-Clairac","year":"2008","unstructured":"Cizeron-Clairac G, Le Panse R, Frenkian-Cuvelier M, Meraouna A, Truffault F, Bismuth J, et al. Thymus and Myasthenia Gravis: what can we learn from DNA microarrays? J Neuroimmunol. 2008;201\u2013202:57\u201363.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"179_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","volume":"108","author":"A Meraouna","year":"2006","unstructured":"Meraouna A, Cizeron-Clairac G, Panse RL, Bismuth J, Truffault F, Tallaksen C, et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood. 2006;108(2):432\u201340.","journal-title":"Blood"},{"issue":"9","key":"179_CR20","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"179_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2105-5-16","volume":"5","author":"B Zhang","year":"2004","unstructured":"Zhang B, Schmoyer D, Kirov S, Snoddy J. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics. 2004;5:16.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"179_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/toxsci\/68.1.93","volume":"68","author":"CL Merrill","year":"2002","unstructured":"Merrill CL, Ni H, Yoon LW, Tirmenstein MA, Narayanan P, Benavides GR, et al. Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically. Toxicol Sci. 2002;68(1):93\u2013101.","journal-title":"Toxicol Sci"},{"issue":"1","key":"179_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/01926230590522149","volume":"33","author":"KT Morgan","year":"2005","unstructured":"Morgan KT, Jayyosi Z, Hower MA, Pino MV, Connolly TM, Kotlenga K, et al. The hepatic transcriptome as a window on whole-body physiology and pathophysiology. Toxicol Pathol. 2005;33(1):136\u201345.","journal-title":"Toxicol Pathol"},{"issue":"4","key":"179_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1474-9726.2007.00306.x","volume":"6","author":"CH Zhu","year":"2007","unstructured":"Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, et al. Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell. 2007;6(4):515\u201323.","journal-title":"Aging Cell"},{"key":"179_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-065X.1998.tb01190.x","volume":"163","author":"SJ Tzartos","year":"1998","unstructured":"Tzartos SJ, Barkas T, Cung MT, Mamalaki A, Marraud M, Orlewski P, et al. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev. 1998;163:89\u2013120.","journal-title":"Immunol Rev"},{"issue":"1\u20132","key":"179_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/08830189709068173","volume":"15","author":"PD Hodgkin","year":"1997","unstructured":"Hodgkin PD, Chin SH, Bartell G, Mamchak A, Doherty K, Lyons AB, et al. The importance of efficacy and partial agonism in evaluating models of B lymphocyte activation. Int Rev Immunol. 1997;15(1\u20132):101\u201327.","journal-title":"Int Rev Immunol"},{"key":"179_CR27","first-page":"40","volume":"9","author":"A Steensberg","year":"2003","unstructured":"Steensberg A. The role of IL-6 in exercise-induced immune changes and metabolism. Exerc Immunol Rev. 2003;9:40\u20137.","journal-title":"Exerc Immunol Rev"},{"issue":"7","key":"179_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.tem.2009.04.002","volume":"20","author":"DR Clemmons","year":"2009","unstructured":"Clemmons DR. Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol Metab. 2009;20(7):349\u201356. doi:S1043-2760(09)00090-3.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"179_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","volume":"169","author":"C Deng","year":"2002","unstructured":"Deng C, Goluszko E, Tuzun E, Yang H, Christadoss P. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production. J Immunol. 2002;169(2):1077\u201383.","journal-title":"J Immunol"},{"issue":"11","key":"179_CR30","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1074\/jbc.M509782200","volume":"281","author":"C Weigert","year":"2006","unstructured":"Weigert C, Hennige AM, Lehmann R, Brodbeck K, Baumgartner F, Schauble M, et al. Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells. The Journal of biological chemistry. 2006;281(11):7060\u20137. doi:10.1074\/jbc.M509782200.","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"179_CR31","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jcb.23420","volume":"113","author":"N Al-Shanti","year":"2012","unstructured":"Al-Shanti N, Stewart CE. Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3. Journal of cellular biochemistry. 2012;113(3):923\u201333. doi:10.1002\/jcb.23420.","journal-title":"Journal of cellular biochemistry"},{"issue":"12","key":"179_CR32","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.2337\/db07-1062","volume":"57","author":"I Nieto-Vazquez","year":"2008","unstructured":"Nieto-Vazquez I, Fernandez-Veledo S, de Alvaro C, Lorenzo M. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes. 2008;57(12):3211\u201321. doi:10.2337\/db07-1062.","journal-title":"Diabetes"},{"issue":"2","key":"179_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1113\/expphysiol.2012.068189","volume":"98","author":"SS Welc","year":"2013","unstructured":"Welc SS, Clanton TL. The regulation of interleukin-6 implicates skeletal muscle as an integrative stress sensor and endocrine organ. Experimental physiology. 2013;98(2):359\u201371. doi:10.1113\/expphysiol.2012.068189.","journal-title":"Experimental physiology"},{"issue":"1","key":"179_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1006\/bbrc.1995.1168","volume":"207","author":"T Tsujinaka","year":"1995","unstructured":"Tsujinaka T, Ebisui C, Fujita J, Kishibuchi M, Morimoto T, Ogawa A, et al. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun. 1995;207(1):168\u201374. doi:S0006-291X(85)71168-0.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"179_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1172\/JCI118398","volume":"97","author":"T Tsujinaka","year":"1996","unstructured":"Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest. 1996;97(1):244\u20139. doi:10.1172\/JCI118398.","journal-title":"J Clin Invest"},{"issue":"1","key":"179_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2990.2008.00965.x","volume":"35","author":"S Martignago","year":"2009","unstructured":"Martignago S, Fanin M, Albertini E, Pegoraro E, Angelini C. Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR. Neuropathol Appl Neurobiol. 2009;35(1):103\u201310.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8B","key":"179_CR37","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1111\/j.1582-4934.2008.00431.x","volume":"13","author":"J Zamecnik","year":"2009","unstructured":"Zamecnik J, Vesely D, Jakubicka B, Cibula A, Pitha J, Schutzner J, et al. Atrophy of type II fibres in myasthenia gravis muscle in thymectomized patients: steroid-induced change with prognostic impact. J Cell Mol Med. 2009;13(8B):2008\u201318.","journal-title":"J Cell Mol Med"},{"issue":"1\u20132","key":"179_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cyto.2006.05.009","volume":"35","author":"E Tuzun","year":"2006","unstructured":"Tuzun E, Li J, Wanasen N, Soong L, Christadoss P. Immunization of mice with T cell-dependent antigens promotes IL-6 and TNF-alpha production in muscle cells. Cytokine. 2006;35(1\u20132):100\u20136.","journal-title":"Cytokine"},{"issue":"2","key":"179_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","volume":"36","author":"R Aricha","year":"2011","unstructured":"Aricha R, Mizrachi K, Fuchs S, Souroujon MC. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis. J Autoimmun. 2011;36(2):135\u201341.","journal-title":"J Autoimmun"},{"issue":"22","key":"179_CR40","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1128\/MCB.01155-06","volume":"26","author":"S Paschoud","year":"2006","unstructured":"Paschoud S, Dogar AM, Kuntz C, Grisoni-Neupert B, Richman L, Kuhn LC. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Molecular and cellular biology. 2006;26(22):8228\u201341.","journal-title":"Molecular and cellular biology"},{"issue":"5","key":"179_CR41","doi-asserted-by":"crossref","first-page":"R1249","DOI":"10.1152\/ajpregu.00490.2002","volume":"284","author":"G Luo","year":"2003","unstructured":"Luo G, Hershko DD, Robb BW, Wray CJ, Hasselgren PO. IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B. Am J Physiol Regul Integr Comp Physiol. 2003;284(5):R1249\u201354.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"179_CR42","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/ard.2004.032359","volume":"64","author":"G Chevrel","year":"2005","unstructured":"Chevrel G, Granet C, Miossec P. Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis. 2005;64(9):1257\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"179_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.bbrc.2003.09.048","volume":"310","author":"P Keller","year":"2003","unstructured":"Keller P, Keller C, Carey AL, Jauffred S, Fischer CP, Steensberg A, et al. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem Biophys Res Commun. 2003;310(2):550\u20134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"179_CR44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/1531-8249(200011)48:5<696::AID-ANA2>3.0.CO;2-S","volume":"48","author":"S Poea","year":"2000","unstructured":"Poea S, Guyon T, Bidault J, Bruand C, Mouly V, Berrih-Aknin S. Modulation of acetylcholine receptor expression in seronegative myasthenia gravis. Ann Neurol. 2000;48(5):696\u2013705.","journal-title":"Ann Neurol"},{"issue":"Pt 7","key":"179_CR45","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain. 2008;131(Pt 7):1940\u201352.","journal-title":"Brain"},{"issue":"5\u20136","key":"179_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/08916930903555943","volume":"43","author":"AM Gomez","year":"2010","unstructured":"Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, et al. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Autoimmunity. 2010;43(5\u20136):353\u201370. doi:10.3109\/08916930903555943.","journal-title":"Autoimmunity"},{"issue":"1\u20132","key":"179_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0022-510X(92)90149-F","volume":"112","author":"L Austin","year":"1992","unstructured":"Austin L, Bower J, Kurek J, Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J Neurol Sci. 1992;112(1\u20132):185\u201391.","journal-title":"J Neurol Sci"},{"issue":"1","key":"179_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/bbrc.1995.2590","volume":"216","author":"M Cantini","year":"1995","unstructured":"Cantini M, Massimino ML, Rapizzi E, Rossini K, Catani C, Dalla Libera L, et al. Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. Biochem Biophys Res Commun. 1995;216(1):49\u201353.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"179_CR49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.CIR.0000043802.38699.66","volume":"107","author":"U Eriksson","year":"2003","unstructured":"Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, Eugster HP, et al. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation. 2003;107(2):320\u20135.","journal-title":"Circulation"},{"issue":"3","key":"179_CR50","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.4049\/jimmunol.175.3.2018","volume":"175","author":"H Yang","year":"2005","unstructured":"Yang H, Tuzun E, Alagappan D, Yu X, Scott BG, Ischenko A, et al. IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1. J Immunol. 2005;175(3):2018\u201325.","journal-title":"J Immunol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-014-0179-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-014-0179-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-014-0179-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-014-0179-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T23:41:41Z","timestamp":1690846901000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-014-0179-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1186\/s40478-014-0179-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,15]]},"assertion":[{"value":"23 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}